FDA MAP
  • Home
  • Workshops
  • WEBINARS
  • Regulatory Services
  • Quality Assurance
  • Custom Training
Newsletter - September 14, 2017
​
Can FDA Do Anything About The Price of Drugs to Consumers?  
 ​
Why are drugs expensive; is it because the cost of developing new drugs is very high, or that there are onerous regulatory processes for market approval, or may be it takes too long to develop a new drug? And if all these were addressed would it lead to cheaper drugs? Read More

Expedited FDA Approval Leads to Unsafe Drugs? No. 


It has been argued that because expedited approval pathways allow drugs to be approved with incomplete analysis of safety and efficacy, it potentially leads to new drugs with limited benefit and/or with potential safety concerns. But this is a simplistic one sided argument that does not address the context in which such drugs are approved. Read More

Our Services

  • Workshops
  • Webinars
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions
  • Corporate Registration
  • Certification Program
  • Smart Recruitment
  • Corporate Registration - Online Workshop

Company

  • About Us
  • Our Instructors
  • Testimonials
  • Free Resources
  • Newsletter
  • Videos (Free Tutorials)

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy
  • News Archive
Consultation Service
FDA Training Company
Copyright © 2019 FDAMap.com
Use of this Web site constitutes acceptance of the FDAMap Terms of Use and Privacy Policy.